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Background: The conventional method for decalcification of bone specimens uses hydrochloric 
acid (HCl) and is notorious for damaging cellular RNA, DNA, and proteins, thus complicating mo-
lecular and immunohistochemical analyses. A method that can effectively decalcify while preserv-
ing genetic material is necessary. Methods: Pairs of bilateral bone marrow biopsies sampled from 
53 patients were decalcified according to protocols of two comparison groups: EDTA versus HCl 
and RDO GOLD (RDO) versus HCl. Pairs of right and left bone marrow biopsy samples harvested 
from 28 cases were allocated into the EDTA versus HCl comparison group, and 25 cases to the 
RDO versus HCl comparison group. The decalcification protocols were compared with regards to 
histomorphology, immunohistochemistry, and molecular analysis. For molecular analysis, we ran-
domly selected 5 cases from the EDTA versus HCl and RDO versus HCl groups. Results: The de-
calcification time for appropriate histomorphologic analysis was the longest in the EDTA method 
and the shortest in the RDO method. EDTA was superior to RDO or HCl in DNA yield and integri-
ty, assessed via DNA extraction, polymerase chain reaction, and silver in situ hybridization using 
DNA probes. The EDTA method maintained intact nuclear protein staining on immunohistochem-
istry, while the HCl method produced poor quality images. Staining after the RDO method had 
equivocal results. RNA in situ hybridization using kappa and lambda RNA probes measured RNA 
integrity; the EDTA and RDO method had the best quality, followed by HCl. Conclusions: The 
EDTA protocol would be the best in preserving genetic material. RDO may be an acceptable al-
ternative when rapid decalcification is necessary.
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▒ ORIGINAL ARTICLE ▒
Sampling bone tissue is usually performed for the diagnosis 
of hematologic malignancy, metastatic tumor, or primary bone 
tumor. The processing of bone specimens usually follows decal-
cification and microtome sectioning in pathology laboratories. 
Inorganic acids such as nitric acid or HCl are used in decalcifi-
cation, and limit diagnostic options by damaging DNA and 
RNA. As a result, gene testing is usually not plausible with 
these decalcified bone specimens, even though certain cancers 
need further genetic studies for diagnostic and therapeutic pur-
poses. Therefore, there is a growing need for new decalcification 
agents that adequately preserve DNA and RNA.1-3
A variety of molecular testing techniques are necessary to di-
agnose hematologic malignancies. Fluorescence in situ hybridiza-
tion, gene rearrangement studies of immunoglobulin and T cell 
receptor genes, and in situ hybridization for kappa and lambda 
light chains and Epstein-Barr virus–encoded small RNAs are 
commonly used molecular tools in diagnosis of hematologic ma-
lignancies. However, further molecular study from bone mar-
row biopsy specimens is often impossible due to DNA or RNA 
damage by decalcification. Furthermore, immunohistochemistry 
may be required for differentiating and subtyping hematolym-
phoid lesions in conjunction with histomorphologic features of 
paratrabecular, interstitial, intrasinusoidal, or intravascular ag-
gregates within bone marrow structures. HCl degrades both 
protein quality and quantity, resulting in poor immunohisto-
chemical staining that cannot be used for accurate diagnosis.
With consideration of these limitations, we evaluated modi-
fied bone marrow decalcification protocols and compared them 
to the HCl method. 
MATERIALS AND METHODS
This was a prospective study. To eliminate bias due to vari-
ables among cases, cases were enrolled when pairs of bilaterally 
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biopsied bone marrow specimens were available. Among bone 
marrow specimens sampled from the right and left iliac crests 
between January 2013 and July 2014 at Gangnam Severance 
Hospital, 53 cases were finally included. For the 53 selected cases, 
28 right and left bone marrow samples were allocated to the 
EDTA (Sigma-Aldrich, St. Louis, MO, USA) protocol and HCl 
(Calci-Clear Rapid, National Diagnostics, Atlanta, GA, USA) 
protocol, respectively. Samples from the 25 remaining cases were 
assigned to the RDO GOLD (RDO) group (Apex Engineering 
Products Corporation, Aurora, IL, USA) protocol and HCl pro-
tocol. Concentration, processing time, and temperature are sum-
marized in Table 1.
To test DNA quality, five cases were randomly selected from 
each of the three groups (EDTA, HCl, and RDO). DNA was ex-
tracted, and the quantity and quality were confirmed using 
NanoDrop ND-2000 spectrophotometer (Thermo Fisher Scien-
tific Inc., Waltham, MA, USA). The BRAF PNA clamping 
method (Panagene, Daejeon, Korea) and comparison with Ct 
values of internal controls were used to evaluate the efficacy of 
polymerase chain reaction (PCR) DNA amplification. To evalu-
ate the efficacy of DNA in situ hybridization, HER2 dual color 
silver in situ hybridization (Ventana, Tucson, AZ, USA) was ap-
plied to 10 pairs of bone marrow samples. RNA in situ hybrid-
ization and immunohistochemical studies were performed pro-
spectively. According to the potential differential diagnoses for 
suspicious lesions observed within bone marrow, appropriate 
RNA probes or protein antibodies were applied. For immuno-
histochemistry, the following primary antibodies were used and 
the details are summarized in Table 2: cyclin D1, Ki67, Bcl2, 
Bcl6, TdT, CD138, CD20, CD79a, CD3, CD5, CD23, CD10, 
CD30, and myeloperoxidase. To state the process, after deparaf-
finization and rehydration, the sections were incubated in 
BenchMark XT automated slide stainer (Ventana) for 16 min-
utes at 37°C and then counterstained with hematoxylin reagent. 
Two pathologists reviewed the hematoxylin and eosin (H&E), 
immunohistochemistry, and in situ hybridization slides. The 
quality of immunohistochemistry and RNA in situ hybridiza-
tion were assessed using a 3-tiered grading scale: good, equivo-
cal, or poor. HER2 silver in situ hybridization was assessed by 
Table 1. The decalcification protocols of three methods
Solution Processing time (hr) Processing temperature
HCl (100%) 3 Room temperature
EDTA (12.5%) 3 or 24a Room temperature
RDO (100%) 0.5–1 Room temperature
HCl, hydrochloric acid; EDTA, ethylenediaminetetraacetic acid disodium 
salt dehydrate; RDO, RDO GOLD.
aThe processing time of EDTA method was mostly 3 hours. It was 24 hours 
for few cases that contained more cortical bone due to the oblique direc-
tion when inserting biopsy-needle.
Table 2. Primary antibodies used
Product name Dilution Clonality Clone Company
Cyclin D1 (SP4) 1:50 Monoclonal SP4 LabVisiona
Ki67 1:1,000 Monoclonal MIB-1 DAKOb
Bcl2 Bond-III 1:50 Monoclonal bcl2/100/D5 Novocastrac
Bcl6 Prediluent Monoclonal LN22 Novocastra
TdT 1:100 Polyclonal - Cell Marqued
CD138 Prediluent Monoclonal ML15 DAKO
CD20 1:400 Monoclonal L26 Novocastra
CD79a (B cell) 1:100 Monoclonal JCB117 DAKO
CD3 1:200 Monoclonal SP7 LabVision
CD5 1:100 Monoclonal 4C7 Novocastra
CD23 1:100 Monoclonal SP23 LabVision
CD10 1:75 Monoclonal 56C6 Novocastra
CD30 1:50 Monoclonal Ber-H2 DAKO
Myeloperoxidase 1:2,000 Polyclonal - DAKO
aLab vision, Waltham, MA; bDAKO, Carpinteria, CA; cNovocastra, Buffalo Grave, IL; dCell Marque, Rocklin, CA. 
Table 3. Quantity and quality of DNA according to decalcification protocols
DNA yield (median, range) p-value Ct value (median, range) p-value
EDTA vs HCl EDTA
HCl
25 (11.0–37.0)
12 (11.0–28.0)
.168 25.0 (24.6–27.2)
32.7 (28.9–33.3)
< .001
RDO vs HCl RDO
HCl
14.7 (10.9–15.0)
13.4 (10.0–15.3)
.753 33.6 (33.0–34.1)
33.5 (33.2–35.2)
.754
Mann-Whitney U test was used to compare the median of each variables.
HCl, hydrochloric acid; EDTA, ethylenediaminetetraacetic acid disodium salt dehydrate; RDO, RDO GOLD. 
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detecting two signals of HER2 and CEP17 per nucleus from 
the normal hematopoietic cells of bone marrow.
The differences in variables were analyzed using the Mann-
Whitney U test. All statistical analyses were carried out by SPSS 
ver. 20.0 for Windows (IBM Co., Armonk, NY, USA).
RESULTS
Isolated DNA quality
DNA quantity, purity, and Ct values of internal controls after 
real-time PCR in the EDTA versus HCl group and RDO versus 
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Fig. 1. The quality, quantity, and feasibility of real time PCR study is compared between EDTA, RDO, and HCl protocols. The first row dem-
onstrates EDTA versus HCl, and the second row RDO versus HCl (A, D, DNA yield; B, PCR result of EDTA; E, PCR result of RDO; C, F, PCR 
results of HCl). D, PCR result of RDO. PCR, polymerase chain reaction; EDTA, ethylenediaminetetraacetic acid disodium salt dehydrate; 
RDO, RDO GOLD; HCl, hydrochloric acid; PNA, peptide nucleic acid.
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Table 4. Comparison of the immunohistochemical results
Item
EDTA vs HCl RDO vs HCl
EDTA HCl RDO HCl
HER2/CEP17 SISH 5/5 (100)a 0/5 (0) 0/5 (0) 0/5 (0)
Kappa ISH 7/7 (100) 4/7 (57.1) 2/3 (66.7) 2/3 (66.7)
Lambda ISH 5/5 (100) 1/5 (20) 2/2 (100) 0/2 (0)
CyclinD1 9/9 (100) 2/9 (22.2) 3/3 (100) 1/3 (33.3)
Ki67 9/9 (100) 5/9 (55.6) 10/10 (100) 6/10 (45.5)
Bcl2 1/1 (100) 1/1 (100) 4/4 (100) 4/4 (100)
Bcl6 No data No data 1/1 (100) 1/1 (100)
TdT No data No data 1/1 (100) 0/1 (0)
CD138 7/7 (100) 7/7 (100) 3/3 (100) 3/3 (100)
CD20 9/9 (100) 9/9 (100) 9/9 (100) 9/9 (100)
CD79a (B cell) No data No data 2/2 (100) 2/2 (100)
CD3 5/5 (100) 5/5 (100) 4/4 (100) 4/4 (100)
CD5 No data No data 3/3 (100) 3/3 (100)
CD23 No data No data 1/1 (100) 1/1 (100)
CD10 1/1 (100) 1/1 (100) 1/1 (100) 1/1 (100)
CD30 1/1 (100) 1/1 (100) No data No data
Myeloperoxidase 1/1 (100) 1/1 (100) 2/2 (100) 2/2 (100)
HCl, hydrochloric acid; EDTA, ethylenediaminetetraacetic acid disodium salt dehydrate; RDO, RDO GOLD; SISH, silver in situ hybridization; ISH, in situ hybrid-
ization. 
aCase number showing intact stain result among overall case number stained with each item (%). Positive expression in the indicated tumor cells or internal 
controls was considered as intact stain. For example, positive expression of cyclin D1 in mantle cell lymphoma cells or endothelial cells was interpreted as in-
tact stain result.
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HCl group are depicted in Table 3 and Fig. 1. Although differ-
ences were not statistically significant, the DNA yield of the 
EDTA protocol was about 2 times higher than the HCl proto-
col. In addition, the Ct value of the former protocol was signifi-
cantly lower than that of the latter (p < .001) with the estimated 
difference being about 7. Furthermore, the Ct values of EDTA 
processed samples were lower than 30, demonstrating that the 
amount of intact DNA feasible for PCR with the EDTA proto-
col is better preserved by a factor of 27 than the HCl protocol.
There were no significant differences between DNA yield and 
Ct values of RDO and HCl methods. The yield of extracted 
DNA after RDO decalcification was similar to that of HCl. The 
Ct values of both protocols were above 33, indicating that the 
amount of intact DNA feasible for PCR was very small. 
Morphological comparison of DNA, RNA, and protein 
expression
The morphological comparison and quality assessment of 
H&E stain, HER2/CEP17 dual color silver in situ hybridization, 
kappa/lambda in situ hybridization, and immunohistochemistry 
studies were analyzed. The rates of high quality staining for each 
study were compared between the three protocols. The results 
are summarized in Table 4.
There was no difficulty in microtome dissection of 4 µm or 
less in thickness in any of the three methods. The morphological 
quality of H&E slide was similar in all three protocols, showing 
well-preserved histological features of the bone marrow (Fig. 2).
All five cases in the RDO versus HCl group had severe DNA 
breakdown on HER2/CEP17 dual color silver in situ hybridiza-
tion, revealing no HER2 or CEP17 nuclear signal in bone mar-
row hematopoietic cells. However, in the EDTA versus HCl 
group, all 5 cases in the EDTA protocol showed two HER2 and 
CEP17 nuclear signals from almost all of the hematopoietic 
cells, whereas nearly no nuclear signal was detected in samples 
from the HCl protocol (Fig. 3).
Bone marrow specimens from the EDTA and RDO protocols 
that underwent kappa/lambda RNA in situ hybridization 
showed well preserved RNA signal in the nuclei of plasma cells, 
while those in the HCl group had severe breakdown of RNA 
signals (Fig. 4). 
Nuclear proteins such as Ki67, cyclin D1, and TdT were rela-
tively better preserved on immunohistochemistry with both 
EDTA and RDO protocols, while samples from the HCl proto-
col showed breakdown and lower quality of nuclear protein 
staining (Fig. 5A–H). Immunohistochemistry targeting the cy-
toplasmic membrane or cytoplasmic CD markers was well pre-
served in all three protocols (Fig. 5I–L). 
DISCUSSION
There have been several studies comparing several types of de-
calcification protocols to date. Some retrospective studies com-
pared the morphology of in situ hybridization or immunohisto-
chemistry by using stored tissues containing bone. Other studies 
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Fig. 2. In EDTA versus HCl comparison of a pair of bone marrow sampled from the same patient (A–D, EDTA versus HCl group; A, B, EDTA 
protocol; C, D, HCl protocol), and in RDO versus HCl comparison of a pair of bone marrow sampled from the same patient (E–H, RDO ver-
sus HCl group; E, F, RDO protocol; G, H, HCl protocol), all the three methods of EDTA, RDO, and HCl protocols demonstrate intact and 
well-preserved histological features of bone marrow. EDTA, ethylenediaminetetraacetic acid disodium salt dehydrate; HCl, hydrochloric acid; 
RDO, RDO GOLD.
http://jpatholtm.org/ http://dx.doi.org/10.4132/jptm.2015.03.16
240     •  Choi S-E, et al.
A
C
B
D
Fig. 3. In HER2 dual color silver in situ hybridization study, almost every nucleus in cases of EDTA protocol demonstrates two intact signals 
of HER2 and CEP17, while cases of RDO or HCl protocol barely demonstrate HER2 or CEP17 signals from the nucleus due to the severe 
breakdown of DNA (A, B, comparison of EDTA versus HCl in a pair of bone marrow from the same patients; C, D, comparison of RDO ver-
sus HCl in a pair of bone marrow from the same patients). EDTA, ethylenediaminetetraacetic acid disodium salt dehydrate; RDO, RDO 
GOLD; HCl, hydrochloric acid.
Fig. 4. The quality of RNA is compared in kappa light chain (A–D) and lambda light chain (E–H) RNA in situ hybridization using a pair of bone 
marrow specimens from the same patient. In a case of kappa light chain-restricted plasma cell myeloma, EDTA protocol (A) reveals intact 
quality while HCl (B) protocol shows poor quality in kappa light chain RNA in situ hybridization. In a case of lambda light chain-restricted 
plasma cell myeloma, EDTA protocol (E) reveals intact quality while HCl (F) protocol shows poor quality. In a case of polyclonal plasma cell 
infiltration within the bone marrow, the EDTA and RDO protocol (C and G, respectively) reveal intact quality while HCl (D, H) protocol show 
poor quality in kappa and lambda light chain RNA in situ hybridization, respectively. EDTA, ethylenediaminetetraacetic acid disodium salt de-
hydrate; HCl, hydrochloric acid; RDO, RDO GOLD.
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extracted nucleic acid from stored tissues containing bone and 
compared the quantity, purity, and Ct value of the DNA and/or 
RNA after real-time PCR.1-4 Few studies have used specimens 
sampled with diagnostic purpose in clinical practice. We inves-
tigated the quality of nucleic acid and protein in decalcified 
bone marrow tissue employing several types of genetic tools, 
immunohistochemistry, and morphological assessments. In ad-
dition, we compared the effect of decalcification protocol while 
limiting bias variance, which may be caused by sampling from 
different patients and cell degeneration from long-term storage. 
We prospectively investigated pairs of bone marrow biopsy 
specimens from the same patients sampled for diagnostic pur-
poses in a clinical setting. To our knowledge, this is one of the 
first studies utilizing clinical samples to assess decalcification 
protocols. 
We compared the conventional protocol using HCl, the well-
known alternative protocol using EDTA, and the new protocol 
using RDO. 
All three methods had equally good performance with respect 
to microtome dissection and preservation of cytomorphologic 
and histomorphologic features. The EDTA protocol was superior 
in preserving nucleic acid (DNA and RNA), allowing for the 
feasibility of genetic studies, such as real time PCR and in situ 
hybridization. The EDTA protocol would be an appropriate op-
tion for genetic studies in bone-contained tissues. The present 
study also confirmed that the HCl protocols are inappropriate 
for genetic studies due to the severe damage of genetic material. 
The quality of nucleic acids in the RDO group was equivocal, 
but this method also didn’t seem to be suitable for genetic stud-
ies. In immunohistochemistry targeting nuclear protein, both 
EDTA and RDO were relatively superior to the HCl protocol. 
All three methods showed intact staining in immunohistochem-
istry targeting cytoplasmic membranes or cytoplasm. EDTA 
protocols seem to be the most appropriate in that comprehensive 
immunohistochemical stains can be applied to the specimens 
processed by this protocol. The feasibility of immunohistochem-
istry using specimens processed with the HCl protocol would be 
limited in many cases, especially when immunostaining for nu-
clear proteins is necessary. Immunohistochemical markers can be 
more widely applied in samples processed with the RDO proto-
col than with the HCl protocol, but diagnostic options are still 
more limited than the EDTA protocol.
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Fig. 5. In immunohistochemistry of Ki67 (A–D), EDTA (A) shows intact quality while HCl (B) shows poor quality in a pair of bone marrow sam-
ple from the same patient. A similar result is noted in comparison of RDO (C) versus HCl (D). Nuclear staining of cyclin D1 is intact in EDTA (E), 
while it is not in HCl (F) of a paired bone marrow from the same patient. Nuclear staining of TdT is intact in RDO (G), while it is poor in HCl (H) 
of a paired bone marrow from the same patient. Cytoplasmic membrane staining of CD138 (I–L) reveals intact quality in all three protocols: 
EDTA (I), RDO (K), and HCl (J, L). EDTA, ethylenediaminetetraacetic acid disodium salt dehydrate; HCl, hydrochloric acid; RDO, RDO GOLD.
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In this study, the EDTA protocol was the most feasible meth-
od for several types of genetic studies and immunohistochemis-
try. Such advantages of EDTA decalcification protocol are al-
ready widely known.1,5-7 The present study confirms again the 
superiority of the EDTA protocol in a wide range of ancillary 
tests for pathologic diagnosis. The potential of the RDO proto-
col is higher than the conventional HCl protocol; however, it is 
not superior to the EDTA protocol and thus, it cannot be con-
sidered an alternative to EDTA protocols, particularly when ge-
netic studies are needed.
When choosing decalcification agents, cost-effectiveness and 
turn-around time from biopsy to final pathologic diagnosis are 
important issues. HCl costs less and requires less time than us-
ing EDTA. Small bone tissues like bone marrow take about 
three to twenty four hours for decalcification in EDTA protocol, 
but most of the other bone specimens need more time when us-
ing the same protocol. RDO protocols can shorten decalcifica-
tion time, but this agent is also expensive. 
In many cases, bone biopsies are needed for diagnosis of hema-
tologic cancer, metastatic tumors, and primary bone sarcoma; 
these types of cancers usually need further gene-based diagnosis. 
Bone marrow biopsy is widely performed in patients with he-
matologic malignancies and pediatric sarcomas or blastomas. 
Therefore, preserving genetic materials is critical in handling 
bone marrow tissues, and cost and turn-around time may be less 
important in such cases. Preserving intact nucleic acid, as well as 
intact proteins, is critical to providing not only accurate patho-
logic diagnosis but also diverse therapeutic options to the pa-
tients. Considering this, in this study the EDTA protocol was 
the most appropriate method for handling bone marrow speci-
mens. RDO may also be useful in that it requires less decalcifi-
cation time and it enables more ancillary tests than HCl, but its 
usefulness is limited by less potential for genetic studies in pro-
cessed samples than EDTA.
In this era of expanding genetic molecular study, better tissue 
handling methods are needed. The present study suggests an ap-
propriate approach in handling bone marrow tissues, and this 
approach should be expanded to other types of tissue specimens.
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